glp 1 negative effects GLP-1: The Diabetes Drug Changing How We Think About Weight Loss A Closer Look at the

With this in mind, here were going to take a look at the pharmacokinetics of the two big boys (WeGovy and Mounjaro) and think about the impact those may have on the expected effects with type 1, and potentially the corroloary effects when used for other conditions

See our Mounjaro vs Ozempic guide

Always consult your healthcare provider to determine which prescription medication aligns with your medical history, body mass index and weight loss goals

GLP-1 prescriptions for those aged 18 to 39 increased 588%, from 0.19% in 2019 to 1.33% in 2024

*Correspondence: Arjola Bano, [email protected] These authors have contributed equally to this work This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers